acetyl l carnitine for frontal temporal dementia Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance its mode of action in Alzheimer's disease and geriatric depression Acetyl-L-Carnitine
Description
2007 ISS Consensus Workshop participants
More recent studies, such as those conducted with NFPS in 2021, reinforce the therapeutic potential of selective GlyT1 inhibitors in the treatment of neuropathic pain
2009;128:e17080
A group treated with LPS (1 g/mL) was used as the positive control
